Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Finasteride reduces prostate size and symptoms with few side effects.

Balding and low testosterone increase risk of urinary stones.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Finasteride may reduce bleeding after TURP, but more research needed.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

A new compound that could treat various androgen-related conditions was created and analyzed.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

A new compound was made that might help treat diseases related to male hormones.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.